Acetate
- Generic Name
- Acetate
- Drug Type
- Small Molecule
- Chemical Formula
- C2H3O2
- CAS Number
- 71-50-1
- Unique Ingredient Identifier
- 569DQM74SC
The Role of GLP-1 in Satiety Perception in Humans
- Conditions
- Appetite RegulationObesity
- Interventions
- Drug: Saline 0.9%
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2015-06-19
- Lead Sponsor
- University of Washington
- Registration Number
- NCT01152333
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
- Conditions
- Prostate CancerCastrate Resistant Prostate Cancer
- Interventions
- Radiation: PET Acetate scan
- First Posted Date
- 2010-06-16
- Last Posted Date
- 2018-10-02
- Lead Sponsor
- Daniel Vaena
- Target Recruit Count
- 5
- Registration Number
- NCT01144897
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Research Investigation of Soy and Estrogen
- Conditions
- MenopauseHot Flashes
- Interventions
- Dietary Supplement: Soy PhytoestrogenDrug: Soy Placebo
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 96
- Registration Number
- NCT00997893
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis
- Conditions
- Relapsing Remitting Multiple Sclerosis
- Interventions
- First Posted Date
- 2009-07-15
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT00939549
- Locations
- 🇺🇸
Johns Hopkins Hospital Multiple Sclerosis Center, Baltimore, Maryland, United States
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
- First Posted Date
- 2009-05-29
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 73
- Registration Number
- NCT00910091
- Locations
- 🇧🇪
Centre Jules Bordet, Bruxelles, Belgium
🇧🇪Onze-Lieve-Vrouwzickenhuis-Campus Aalst, Aalst, Belgium
🇫🇷Hôpital Jean Minjoz, Besançon, France
Androcur Effects on Quality of Life
- First Posted Date
- 2009-05-27
- Last Posted Date
- 2010-04-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 245
- Registration Number
- NCT00908674
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
- Conditions
- BreastfeedingContraception
- Interventions
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 40
- Registration Number
- NCT00828542
- Locations
- 🇧🇷
University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
- Conditions
- Infertility
- Interventions
- Drug: Antagonist GnRH Cetrotide
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA
- Target Recruit Count
- 570
- Registration Number
- NCT00633347
- Locations
- 🇪🇸
IVI Valencia, Valencia, Spain
A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer
- Conditions
- Malnourished Children With Cancer
- Interventions
- Other: Placebo
- First Posted Date
- 2007-02-23
- Last Posted Date
- 2012-07-13
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 26
- Registration Number
- NCT00439101
- Locations
- 🇨🇦
Stollery Children's Hospital, Edmonton, British Columbia, Canada
🇨🇦Children's & Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada
Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure
- Conditions
- Premature Ovarian Failure
- First Posted Date
- 2006-08-30
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Registration Number
- NCT00370019
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.